about
Emerging risk factors and the dose-response relationship between physical activity and lone atrial fibrillation: a prospective case-control studyEpidemiology and prognosis of coagulase-negative staphylococcal endocarditis: impact of vancomycin minimum inhibitory concentration.High-dose daptomycin plus fosfomycin is safe and effective in treating methicillin-susceptible and methicillin-resistant Staphylococcus aureus endocarditis.Association between valvular surgery and mortality among patients with infective endocarditis complicated by heart failure.Clinical utility of daptomycin in infective endocarditis caused by Gram-positive cocci.Percutaneous transcatheter aortic valve implantation: present and future perspective.Infective endocarditis in patients with an implanted transcatheter aortic valve: Clinical characteristics and outcome of a new entity.Enterococcal endocarditis revisited.Transcatheter aortic valve implantation in patients with left main percutaneous coronary intervention.Early in vitro and in vivo development of high-level daptomycin resistance is common in mitis group Streptococci after exposure to daptomycin.Transfemoral transcatheter aortic valve replacement compared with surgical replacement in patients with severe aortic stenosis and comparable risk: cost-utility and its determinants.Prognosis of new-onset heart failure outpatients and collagen biomarkers.Daptomycin is effective for treatment of experimental endocarditis due to methicillin-resistant and glycopeptide-intermediate Staphylococcus epidermidis.Changes in the treatment of Enterococcus faecalis infective endocarditis in Spain in the last 15 years: from ampicillin plus gentamicin to ampicillin plus ceftriaxone.Influence of vegetation size on the clinical presentation and outcome of lead-associated endocarditis: results from the MEDIC registry.Efficacy and safety of outpatient parenteral antibiotic therapy for infective endocarditis: a ten-year prospective study.Risk factors for pericardial effusion in native valve infective endocarditis and its influence on outcome.Lung function abnormalities are highly frequent in patients with heart failure and preserved ejection fraction.Left atrial dysfunction relates to symptom onset in patients with heart failure and preserved left ventricular ejection fraction.[Acute coronary syndrome during oral capecitabine monotherapy].Interatrial Dyssynchrony May Contribute to Heart Failure Symptoms in Patients with Preserved Ejection Fraction.Randomized clinical trial of the effectiveness of a home-based intervention in patients with heart failure: the IC-DOM study.Diagnóstico de la insuficiencia cardíaca con fracción de eyección preservada o reducida mediante una consulta de alta resoluciónIntegración entre cardiología y atención primaria: impacto sobre la práctica clínica[Cardiac tamponade in acute pericarditis: is drainage with intrapericardial catheter indicated?][Metastatic cardiac tamponade in a patient with papillary carcinoma of the thyroid][Aortic endocarditis after implantation of a provisional pacemaker][Evaluation of left ventricular contraction using heart tomography with technetium 99m tetrofosmin in synchrony with ECG. Correlation with bidimensional echocardiography][An educative intervention to improve treatment compliance and to prevent readmissions of elderly patients with heart failure][One-stop outpatient cardiology clinics: 10 years' experience][Antibiotic prophylaxis for infectious endocarditis: who needs it and when to recommend it]Neglecting enterococci may lead to a misinterpretation of the consequences of last changes in endocarditis prophylaxis American Heart Association guidelinesPrevention of infective endocarditis: between progress in scientific knowledge and the lack of randomized trialsPrevention of infective endocarditis from the dentist's perspective. ResponseRisk factors of pericardial effusion in native valve infective endocarditis and its influence on outcome: A multicenter prospective cohort study
P50
Q27301925-EFB4902B-2D79-4FD1-BC29-4BCA0CC97DBBQ35593072-40EFBC6F-8184-4248-8B58-731DE2EBAEABQ36171512-2D5E3EEE-EB8E-40F6-925E-2C638FD21B6CQ37270240-3AEE09AF-9206-47A5-8E86-C9B94E4CB24DQ37855179-FA9DF412-3ED8-4C78-86E8-244AF72E630AQ38088269-38665BBE-0D6B-4D7E-8C5F-6988D2D33C2CQ38308382-1CA743C5-1ED8-4409-AAC1-4CB982D8A64DQ38539279-F4F04A8B-D46C-4CCC-89E5-CFCE8169005BQ39238499-7060C621-2CB3-4708-B905-9C9AE12E15C3Q40003948-AAB28D8F-6F37-494F-8C0B-FEEF1585C06CQ41587927-A75264F9-5884-4E2C-9A33-F033E37E464BQ41666901-8B89A6F3-7D18-4BD9-B60B-9AA5B871E061Q41874503-7375058B-20F6-44E7-92E1-D8E689B86B2CQ42205464-F40738E2-07AC-4843-8B02-1EB35E68CAF5Q42215956-EF1C8392-50B6-4492-96AE-8231CB11B687Q43559514-670C546F-3115-41C6-9999-191E085D9DC9Q43601323-8372EED7-D282-498D-AAC8-8CC8FAACC619Q43838040-BFC92F51-3B75-4FC4-93C7-927CCDA46296Q44017244-C8DDF094-D67B-4AAB-A4E8-AD3889E461C8Q46607876-D1DCCDD5-1BA0-434C-9850-3F62A4FE0F22Q48682326-D7D30014-38A2-4466-A3AF-E6EDD978B015Q53106513-B751553A-3825-431F-AF30-8BCE4BC7781CQ60492240-5BD3E5B7-E2D8-477C-A884-D94C5D6EB42CQ60492241-24E137ED-399A-4D5E-8498-9E2081C2803FQ71132767-C0DE669E-D403-4E87-AF9F-4D7E12CB2E7EQ71399951-76D70C39-E3B1-4686-B1BE-E482EE3562ADQ73967914-9CB6AFEB-0D29-4F7D-A127-A594AC91448DQ74527294-A9E7FBD6-0DC1-4E41-9ECD-0585FD27DBC8Q79630549-6BA0FA8A-8828-4912-B724-BDDAE017D585Q81231635-DAB93C9F-7BED-4482-9085-A7AADC84923CQ83758001-198B400A-C7BD-408B-918E-56AFB951BFAAQ86635894-06DD1BE7-0B62-4CE4-809D-5BCE0169D3B5Q87414652-090471ED-3BFF-4299-8D7F-CF731FD063F9Q87772274-0DE6C18E-AA6F-41F7-BC5F-4D7E6A37F04DQ91025475-5AA4FC9C-3C84-4984-8737-A1B1D76DD671
P50
description
researcher ORCID ID = 0000-0002-3483-3786
@en
wetenschapper
@nl
name
Carlos Falces
@ast
Carlos Falces
@en
Carlos Falces
@es
Carlos Falces
@nl
type
label
Carlos Falces
@ast
Carlos Falces
@en
Carlos Falces
@es
Carlos Falces
@nl
altLabel
Falces C
@en
prefLabel
Carlos Falces
@ast
Carlos Falces
@en
Carlos Falces
@es
Carlos Falces
@nl
P106
P1153
6602913737
P21
P31
P496
0000-0002-3483-3786